Seattle Genetics (SGEN) in Focus After Tops Q4 EPS by 2c, Provides Outlook
Tweet Send to a Friend
Seattle Genetics Inc. (NASDAQ: SGEN) reported Q4 EPS of ($0.09), $0.02 better than the analyst estimate of ($0.11). Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
